The FDA advisers, a group of independent vaccine experts, will discuss Pfizer and BioNTech’s clinical trial data, which the agency confirmed showed the shot was 95% effective and worked well regardless of age, gender, race, ethnicity or underlying conditions that cause people to be at high risk of severe Covid-19 symptoms. The vaccine is expected to be the first made available in the U.S., where about 290,000 people have died from the virus.



Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *